#27 – Greg Divis, CEO Of Avadel Pharmaceuticals

from BioBreakthroughs · host Slice of Healthcare LLC

Join us on the latest episode! Our Guest: Greg Divis, CEO at Avadel PharmaceuticalsWhat you'll get out of this episode:Discussing LUMRYZ, a new narcolepsy drug.Insights into the challenges of narcolepsy treatment.Avadel's future plans in healthcare innovation.To learn more about Greg and Avadel Pharmaceuticals:Guest LinkedIn: https://www.linkedin.com/in/greg-divis-a525334/Website: https://www.avadel.com/Company LinkedIn: https://www.linkedin.com/company/avadelpharmaceuticals/Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network: LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

What this episode covers

NOW PLAYING

0:00 16:25

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBreakthroughs?

This episode is 16 minutes long.

When was this BioBreakthroughs episode published?

This episode was published on December 29, 2023.

What is this episode about?

Can I download this BioBreakthroughs episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!